Answers are grounded in this paper and cite their sources.
Aim: This study aimed to clarify the anti-fibrotic potential of bone marrow-derived mesenchymal stem cells (BM-MSCs), compared to conditioned media (CM), in amiodarone (AD)-induced lung fibrosis. Methods: A total of 64 Wistar rats were categorized into eight groups: negative control group, positive control group, 3 AD-challenged-BM-MSCs-treated groups (1, 2 and 4 months) and 3 AD- challenged-CM-treated groups (1, 2 and 4 months). Serum macrophage in ammatory protein 2 (MIP-2) evels were measured. Gene expression levels of TGF-1, SMAD3 and S100A4, were estimated in the lung tissues. Results: Treatment with BM-MSCs/CM mediated a significant reduction in serum MIP-2 concentrations, while downregulating AD-induced up-regulation of lung TGF-1, SMAD3 and S100A4 gene expression levels. BM-MSCs transplantation revealed better effect than CM in mitigating lung fibrosis. Conclusion: BM-MSCs advance anti-fibrotic effect on lung fibrosis by targeting inflammatory response and TGF-B1 signaling.
No takes yet. Share an insight, caveat, or question.
Halim et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: